ValuEngine Upgrades Medical Transcription Billing (MTBC) to “Hold”
ValuEngine upgraded shares of Medical Transcription Billing (NASDAQ:MTBC) from a sell rating to a hold rating in a research note released on Tuesday.
Several other equities analysts also recently issued reports on MTBC. Zacks Investment Research raised shares of Medical Transcription Billing from a sell rating to a hold rating in a report on Thursday, November 23rd. Chardan Capital increased their price objective on shares of Medical Transcription Billing from $2.25 to $2.75 and gave the company a buy rating in a report on Tuesday, November 14th.
Shares of Medical Transcription Billing (NASDAQ MTBC) opened at $3.88 on Tuesday. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.15 and a quick ratio of 1.15. Medical Transcription Billing has a 52-week low of $0.29 and a 52-week high of $5.44.
WARNING: This story was published by Daily Political and is owned by of Daily Political. If you are viewing this story on another site, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this story can be viewed at https://www.dailypolitical.com/2018/02/23/valuengine-upgrades-medical-transcription-billing-mtbc-to-hold.html.
About Medical Transcription Billing
Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Medical Transcription Billing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing and related companies with MarketBeat.com's FREE daily email newsletter.